OrbiMed’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8M Buy
242,800
+42,800
+21% +$2.17M 0.21% 81
2026
Q2
$10.8M Buy
+200,000
New +$11.2M 0.2% 83

Other funds holding SPRB

OrbiMed's SPRB Position: Q3 2026 in Review

OrbiMed increased its Spruce Biosciences (SPRB) stake by 21% in Q3 2026, buying an estimated $2.17M and bringing the position to 242,800 shares worth $11.8M. The position accounts for 0.21% of the portfolio, ranked #81.

OrbiMed first reported a position in SPRB in Q2 2026 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • OrbiMed held 242,800 shares of Spruce Biosciences worth $11.8M as of Q3 2026.
  • OrbiMed bought 42,800 Spruce Biosciences shares in Q3 2026, an estimated $2.17M.
  • Spruce Biosciences made up 0.21% of OrbiMed's portfolio in Q3 2026, its #81 holding.
  • OrbiMed first reported a position in Spruce Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.